Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from TERT Promoter Variants, Older Age, and Prognosis in Papillary Thyroid Carcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.
Thyroid cancer incidence and mortality trends in the United States: 2000-2018.
10.1089/thy.2021.0662 · 2022 · External reference
Updated American Joint Committee on Cancer/tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer (eighth edition): what changed and why?
10.1089/thy.2017.0102 · 2017 · External reference
An international multi-institutional validation of age 55 years as a cutoff for risk stratification in the AJCC/UICC staging system for well-differentiated thyroid cancer.
10.1089/thy.2015.0315 · 2016 · External reference
Distant metastases from childhood differentiated thyroid carcinoma: clinical course and mutational landscape.
10.1210/clinem/dgaa935 · 2021 · External reference
TERT promoter mutations in thyroid cancer.
10.1530/erc-15-0533 · 2016 · External reference
Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer.
10.1038/s41467-019-10680-5 · 2019 · External reference
Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers.
10.1158/1078-0432.ccr-18-0373 · 2018 · External reference
Molecular signature incorporating the immune microenvironment enhances thyroid cancer outcome prediction.
10.1016/j.xgen.2023.100409 · 2023 · External reference
Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: a matched case-control study.
10.1002/cncr.33421 · 2021 · External reference
TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma.
10.1530/eje-14-0837 · 2015 · External reference
TERT promoter mutations and long-term survival in patients with thyroid cancer.
10.1530/erc-16-0219 · 2016 · External reference
Mortality risk stratification by combining BRAF V600E and TERT promoter mutations in papillary thyroid cancer: genetic duet of BRAF and TERT promoter mutations in thyroid cancer mortality.
10.1001/jamaoncol.2016.3288 · 2017 · External reference
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
10.1210/jc.2013-3734 · 2014 · External reference
Frequency of TERT promoter mutations in real-world analysis of 2,092 thyroid carcinoma patients.
10.3803/enm.2022.1477 · 2022 · External reference
The association between thyroid differentiation score and survival outcomes in papillary thyroid carcinoma.
10.1210/clinem/dgae532 · 2025 · External reference
Integrated genomic characterization of papillary thyroid carcinoma.
10.1016/j.cell.2014.09.050 · 2014 · External reference
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics.
10.1016/j.cell.2018.02.052 · 2018 · External reference
AACR Project GENIE: powering precision medicine through an international consortium.
10.1158/2159-8290.cd-17-0151 · 2017 · External reference
Effect measure modification by covariates in mediation: extending regression-based causal mediation analysis.
10.1097/ede.0000000000001643 · 2023 · External reference
Frequency of TERT promoter mutations in human cancers.
10.1038/ncomms3185 · 2013 · External reference
Understanding TERT promoter mutations: a common path to immortality.
10.1158/1541-7786.mcr-16-0003 · 2016 · External reference
Distinct transcriptional and prognostic impacts of TERT promoter mutations C228T and C250T in papillary thyroid carcinoma.
10.1530/erc-24-0058 · 2024 · External reference
Pathogenesis of cancers derived from thyroid follicular cells.
10.1038/s41568-023-00598-y · 2023 · External reference
Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis.
10.1038/s41588-025-02296-x · 2025 · External reference
2023 European Thyroid Association clinical practice guidelines for thyroid nodule management.
10.1530/etj-23-0067 · 2023 · External reference
2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer.
10.1177/10507256251363120 · 2025 · External reference
Genetic modification of the AJCC classification of papillary thyroid cancer: an international, multicentre, retrospective cohort study.
10.1016/s1470-2045(25)00399-7 · 2025 · External reference
Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma.
10.1371/journal.pone.0294145 · 2023 · External reference
